ACHC:NSD-Acadia Healthcare Company Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 81.94

Change

-2.77 (-3.27)%

Market Cap

USD 7.45B

Volume

1.09M

Avg Analyst Target

USD 88.94 (+8.54%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

ACHC Stock Forecast & Price:
Based on the Acadia Healthcare Company Inc stock forecasts from 10 analysts, the average analyst target price for Acadia Healthcare Company Inc is USD 88.94 over the next 12 months. Acadia Healthcare Company Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Acadia Healthcare Company Inc is Neutral, which is based on 7 positive signals and 6 negative signals. At the last closing, Acadia Healthcare Company Inc’s stock price was USD 81.94. Acadia Healthcare Company Inc’s stock price has changed by -7.99% over the past week, +4.42% over the past month and +38.83% over the last year.

About Acadia Healthcare Company Inc (ACHC:NSD)

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, resident ...Read More

Company Website : https://www.acadiahealthcare.com

Address : 6100 Tower Circle, Franklin, TN, United States, 37067

Employees : 22,500

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 1.26

52 Week High : 89.85

Short Ratio : 5.12

52 Week Low : 50.07

Shorted Shares : 3,712,752

200 Day Moving Average : 75.01

Shorted Shares Previous Month : 4,167,559

50 Day Moving Average : 81.99

Shares Held By Insiders : 1.51%

Short Percentage : 4.72%

Shares Held by Institutions : 103.98%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-12-07 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
OPCH Option Care Health Inc

-0.30 (-1.00%)

 USD5.50B 29.34 21.16
ENSG The Ensign Group Inc

+0.57 (+0.62%)

 USD5.23B 25.14 18.43
LHCG LHC Group

+2.54 (+1.56%)

 USD5.02B 79.28 30.52
SGRY Surgery Partners Inc

+0.32 (+1.21%)

 USD3.31B 63.00 14.11
AMED Amedisys Inc

-0.18 (-0.21%)

 USD2.81B 23.40 13.59
PRSC The Providence Service Corpora..

N/A

 USD2.21B 74.23 15.08
LFST Lifestance Health Group Inc

+0.06 (+1.07%)

 USD2.12B N/A -10.62
ADUS Addus HomeCare Corporation

-0.67 (-0.63%)

 USD1.71B 38.99 23.35
CCRN Cross Country Healthcare Inc

-1.18 (-3.52%)

 USD1.37B 6.11 4.77
AMEH Apollo Medical Holdings Inc

-0.41 (-1.38%)

 USD1.35B 21.00 16.65

ETFs Containing ACHC

Symbol Name Weight Mer Price(Change) Market Cap
CHEP AGFiQ U.S. Market Neutral.. 0.00 % 1.42 %

N/A

 USD0.75M
2B77:XETRA iShares Ageing Population.. 0.00 % 0.40 %

-0.03 (-0.42%)

 USD0.71B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 34.99% 96% A 96% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.99% 96% A 96% A
Trailing 12 Months  
Capital Gain 37.83% 100% A+ 97% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.83% 100% A+ 96% A
Trailing 5 Years  
Capital Gain 153.61% 46% F 89% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 153.61% 46% F 89% B+
Average Annual (5 Year Horizon)  
Capital Gain 27.16% 72% C- 86% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.16% 72% C- 86% B
Risk Return Profile  
Volatility (Standard Deviation) 60.40% 32% F 20% F
Risk Adjusted Return 44.97% 64% D 82% B-
Market Capitalization 7.45B 100% A+ 93% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 26.69 58% F 36% F
Price/Book Ratio 2.90 38% F 30% F
Price / Cash Flow Ratio 19.92 24% F 14% F
EV/EBITDA 16.67 31% F 14% F
Management Effectiveness  
Return on Equity 10.83% 82% B- 75% C
Return on Invested Capital 7.28% 63% D 71% C-
Return on Assets 5.71% 83% B 86% B
Debt to Equity Ratio 58.73% 36% F 33% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 5.12 57% F 27% F
Short Percent 4.72% 69% D+ 31% F
Beta 1.26 43% F 34% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment
Stock Target Advisor

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector